PDCD1 and neoplasm: Furthermore, anti-PD-1 antibody efficacy was largely impaired in MC38-tumor bearing mice receiving fecal microbiota transplantation (FMT) from newly diagnosed colorectal cancer patients compared to mice receiving FMT from healthy controls.